Medis

We are a company with extensive experience of generic pharmaceuticals who offers a broad portfolio of products and intellectual property to other pharmaceutical companies. We have a proven track record in securing regulatory approval prior to patent expiries and have obtained marketing authorizations in over 140 countries to date. Our company draws on the development and manufacturing capabilities of its parent company, Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA), whose R&D specialists maintain a strong development pipeline